DUBLIN, Mar. 11, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the following Product Segments:
Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as:
- AbbVie Inc.
- Acrux Ltd.
- Actavis, Inc.
- Antares Pharma, Inc.
- Auxilium Pharmaceuticals, Inc.
- Bayer HealthCare Pharmaceuticals
- Clarus Therapeutics
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
II. Executive Summary
2. Industry Overview
3. Product Landscape
4. Testosterone Deficiency And Trt - An Overview
5. Product Launches/Approvals
6. Recent Industry Activity
7. Focus On Select Players
8. Global Market Perspective
1. The United States
5. Latin America
6. Rest Of World
IV. Competitive Landscape
Total Companies Profiled: 30 (including Divisions/Subsidiaries - 36)
- The United States (20)
- Canada (4)
- Japan (1)
- Europe (7)
- France (1)
- Germany (1)
- The United Kingdom (2)
- Italy (1)
- Rest of Europe (2)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/b26zrl/testosteron
Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets